Related Experiment Video

Updated: May 18, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Cardiac syndrome X and microvascular coronary dysfunction

Erika Jones1, Wafia Eteiba, Noel Bairey Merz

  • 1Women's Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Trends in Cardiovascular Medicine
|October 3, 2012
PubMed

Insights

Cardiac syndrome X (CSX) in women may stem from microvascular coronary dysfunction (MCD). This condition, similar to obstructive coronary artery disease (CAD), warrants further research due to its prevalence and impact.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Women's Health

Background:

  • Cardiac syndrome X (CSX) is diagnosed in women with myocardial ischemia symptoms but no obstructive coronary artery disease (CAD).
  • A subset of CSX patients experience ischemia due to microvascular dysfunction.
  • Microvascular coronary dysfunction (MCD) is a key mechanism causing angina in women with vascular dysfunction.

Purpose of the Study:

  • To enhance understanding of coronary vascular dysfunction and myocardial ischemia in CSX patients.
  • To highlight the significance of microvascular coronary dysfunction (MCD) as an etiologic mechanism.
  • To establish MCD as a research priority due to its prevalence, prognosis, and treatment gaps.

Main Methods:

  • Review of new data on coronary vascular dysfunction.
  • Analysis of etiological mechanisms in women with cardiac syndrome X.
  • Comparative analysis of MCD with obstructive CAD regarding prognosis and costs.

Main Results:

  • Microvascular coronary dysfunction (MCD) is an important cause of myocardial ischemia in women with CSX.
  • MCD presents an adverse prognosis and healthcare cost burden comparable to obstructive CAD.
  • Current evidence on treatment strategies for MCD is lacking.

Conclusions:

  • Microvascular coronary dysfunction (MCD) is a significant condition in women presenting with cardiac syndrome X.
  • MCD necessitates further research, particularly concerning effective treatment strategies.
  • Addressing MCD is crucial given its prevalence, adverse outcomes, and economic impact.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...